PTIX (Protagenic Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on PTIX (Protagenic Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock m

PTIX

Protagenic Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
Nov 13, 2025
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
Aug 22, 2025
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
Aug 21, 2025
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
Jul 30, 2025
Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity
May 21, 2025
Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders
May 19, 2025
Biotech Alert: Searches spiking for these stocks today
May 10, 2025
Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split
Apr 29, 2025

Reviews